Peptide data sheet
GLOW Stack
Skincare · GLOW · GLOW blend · GLOW peptide stack · GHK-Cu glow stack
Verdict
unprovenThe unproven label is about the stack, not a dismissal of every part. GHK-Cu topical has real cosmetic data; the recovery peptides in the blend lean heavily on animal work. What is genuinely unproven is the combination — no study has tested these three together for the skin-and-recovery outcomes the bundle is sold on.
By MrPepTalks Editorial
Reviewed for scientific accuracy · research information, not medical advice
Last updated Reviewed
Quick answer
The GLOW stack is a blended vial of three research peptides, GHK-Cu, BPC-157 and TB-500, commonly researched for skin appearance and tissue recovery. Each is studied on its own, mostly in early or animal research, and no controlled study has tested the three as a combined stack. It is not FDA-approved.
- Class
- Multi-peptide blend: GHK-Cu (copper tripeptide) + BPC-157 + TB-500 (thymosin beta-4 fragment, LKKTETQ)
- Half-life
- not characterized for the blend (the individual peptides differ)
- FDA status
- Not FDA-approved. Sold for laboratory research use only; the blend and its individual peptides are research-grade materials, not approved drugs.
- WADA banned?
- Yes
Which form actually works?
Topical (as a GHK-Cu-led serum)
Promising
The copper-peptide part of this idea is where the real cosmetic evidence lives. Applied to skin, GHK-Cu has been studied in humans for appearance-related measures, which is why the topical route is the most defensible piece of the whole GLOW concept.
Injectable blend (the vial as sold)
Unproven
The vial that gets marketed as a stack. The recovery peptides in it are mostly backed by animal research, and the three-way combination has never been tested together in people. Convenient packaging is not the same as combined evidence.
Third-Party Testing & Certificate of Analysis (COA)
A certificate of analysis (COA) is a lab document that reports what a specific batch of material actually contains. Reputable research suppliers publish one for every batch, tied to a lot number you can match against the vial you received.
- HPLC — purity
- High-performance liquid chromatography reports purity as a percentage: how much of the sample is the intended compound rather than impurities.
- Mass spectrometry (MS) — identity
- Mass spectrometry confirms identity by measuring the sample's molecular mass, so it matches the peptide the label names.
It also matters who ran the test. In-house results come from the seller's own lab; an independent third-party lab has no stake in the result, so its COA generally carries more weight. Look for a named testing laboratory, a batch or lot number, and a test date that lines up with the vial in hand.
New to reading one? This guide walks through a COA line by line: how to read a peptide COA.
Sources
- Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. Int J Mol Sci, 2018;19(7):1987.
- Gwyer D, Wragg NM, Wilson SL. Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing. Cell Tissue Res, 2019;377(2):153-159.
- Goldstein AL, Hannappel E, Kleinman HK. Thymosin beta4: actin-sequestering protein moonlights to repair injured tissues. Trends Mol Med, 2005;11(9):421-429.
- U.S. Food and Drug Administration. Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks (Category 2). Content current as of 04/22/2026. Lists KPV, and separately "Thymosin beta-4, fragment (LKKTETQ), also known as TB-500", recording that FDA has not identified any human exposure data for either; and GHK-Cu for injectable routes, with limited data in humans.
Related peptides
All Skincare →Frequently asked questions
No spam. Compliant with CAN-SPAM (US), CASL (Canada) & GDPR (EU) · one-click unsubscribe. See our Privacy Policy.